86 related articles for article (PubMed ID: 19111582)
41. Characterization of the tissue-specific expression of the s100P gene which encodes an EF-hand Ca2+-binding protein.
Jin G; Wang S; Hu X; Jing Z; Chen J; Ying K; Xie Y; Mao Y
Mol Biol Rep; 2003 Dec; 30(4):243-8. PubMed ID: 14672411
[TBL] [Abstract][Full Text] [Related]
42. S-phase reduction in T47D human breast cancer epithelial cells induced by an S100P antisense-retroviral construct.
Beissel B; Silva ID; Pesquero JB; Russo J; Schor N; Bellini MH
Oncol Rep; 2007 Mar; 17(3):611-5. PubMed ID: 17273741
[TBL] [Abstract][Full Text] [Related]
43. S100P Interacts with p53 while Pentamidine Inhibits This Interaction.
Katte RH; Dowarha D; Chou RH; Yu C
Biomolecules; 2021 Apr; 11(5):. PubMed ID: 33923162
[TBL] [Abstract][Full Text] [Related]
44. Apoptosis-linked gene product ALG-2 is a new member of the calpain small subunit subfamily of Ca2+-binding proteins.
Lo KW; Zhang Q; Li M; Zhang M
Biochemistry; 1999 Jun; 38(23):7498-508. PubMed ID: 10360947
[TBL] [Abstract][Full Text] [Related]
45. Two-dimensional 1H nuclear magnetic resonance studies of the half-saturated (Ca2+)1 state of calbindin D9k. Further implications for the molecular basis of cooperative Ca2+ binding.
Carlström G; Chazin WJ
J Mol Biol; 1993 May; 231(2):415-30. PubMed ID: 8389885
[TBL] [Abstract][Full Text] [Related]
46. Phosphorylation of ezrin on threonine 567 produces a change in secretory phenotype and repolarizes the gastric parietal cell.
Zhou R; Zhu L; Kodani A; Hauser P; Yao X; Forte JG
J Cell Sci; 2005 Oct; 118(Pt 19):4381-91. PubMed ID: 16144865
[TBL] [Abstract][Full Text] [Related]
47. Ezrin mutants affecting dimerization and activation.
Chambers DN; Bretscher A
Biochemistry; 2005 Mar; 44(10):3926-32. PubMed ID: 15751968
[TBL] [Abstract][Full Text] [Related]
48. A conformational switch in the Piccolo C2A domain regulated by alternative splicing.
Garcia J; Gerber SH; Sugita S; Südhof TC; Rizo J
Nat Struct Mol Biol; 2004 Jan; 11(1):45-53. PubMed ID: 14718922
[TBL] [Abstract][Full Text] [Related]
49. S100P: a novel therapeutic target for cancer.
Arumugam T; Logsdon CD
Amino Acids; 2011 Oct; 41(4):893-9. PubMed ID: 20509035
[TBL] [Abstract][Full Text] [Related]
50. The role of S100P in the invasion of pancreatic cancer cells is mediated through cytoskeletal changes and regulation of cathepsin D.
Whiteman HJ; Weeks ME; Dowen SE; Barry S; Timms JF; Lemoine NR; Crnogorac-Jurcevic T
Cancer Res; 2007 Sep; 67(18):8633-42. PubMed ID: 17875703
[TBL] [Abstract][Full Text] [Related]
51. Ca2+ binding and conformational changes in a calmodulin domain.
Evenäs J; Malmendal A; Thulin E; Carlström G; Forsén S
Biochemistry; 1998 Sep; 37(39):13744-54. PubMed ID: 9753463
[TBL] [Abstract][Full Text] [Related]
52. (1)H, (15)N and (13)C assignments of the calcium bound S100P.
Penumutchu SR; Mohan SK; Yu C
Biomol NMR Assign; 2013 Apr; 7(1):5-8. PubMed ID: 22392334
[TBL] [Abstract][Full Text] [Related]
53. Expression and divalent cation binding properties of the novel chemotactic inflammatory protein psoriasin.
Vorum H; Madsen P; Rasmussen HH; Etzerodt M; Svendsen I; Celis JE; Honoré B
Electrophoresis; 1996 Nov; 17(11):1787-96. PubMed ID: 8982613
[TBL] [Abstract][Full Text] [Related]
54. Activation of tissue plasminogen activator by metastasis-inducing S100P protein.
Clarke CJ; Gross SR; Ismail TM; Rudland PS; Al-Medhtiy M; Santangeli M; Barraclough R
Biochem J; 2017 Sep; 474(19):3227-3240. PubMed ID: 28798096
[TBL] [Abstract][Full Text] [Related]
55. The C2A domain of synaptotagmin-like protein 3 (Slp3) is an atypical calcium-dependent phospholipid-binding machine: comparison with the C2A domain of synaptotagmin I.
Fukuda M
Biochem J; 2002 Sep; 366(Pt 2):681-7. PubMed ID: 12049610
[TBL] [Abstract][Full Text] [Related]
56. Troponin C/calmodulin chimeras as erythrocyte plasma membrane Ca2+-ATPase activators.
Fidalgo da Silva E; Freire MM; Barrabin H; Sorenson MM; Tikunova S; Johnson JD; Chandra M; Pearlstone JR; Scofano HM
Int J Biochem Cell Biol; 2006 Feb; 38(2):209-21. PubMed ID: 16213185
[TBL] [Abstract][Full Text] [Related]
57. Changes in biological activity and folding of guanylate cyclase-activating protein 1 as a function of calcium.
Rudnicka-Nawrot M; Surgucheva I; Hulmes JD; Haeseleer F; Sokal I; Crabb JW; Baehr W; Palczewski K
Biochemistry; 1998 Jan; 37(1):248-57. PubMed ID: 9425045
[TBL] [Abstract][Full Text] [Related]
58. Expression of S100P gene in cervical carcinoma cells is independent of E7 human papillomavirus oncogene.
Jakubícková L; Baráthová M; Pastoreková S; Pastorek J; Gibadulinová A
Acta Virol; 2005; 49(2):133-7. PubMed ID: 16047742
[TBL] [Abstract][Full Text] [Related]
59. Direct interaction of metastasis-inducing S100P protein with tubulin causes enhanced cell migration without changes in cell adhesion.
Du M; Wang G; Barsukov IL; Gross SR; Smith R; Rudland PS
Biochem J; 2020 Mar; 477(6):1159-1178. PubMed ID: 32065231
[TBL] [Abstract][Full Text] [Related]
60. The Role of the C-Terminal Lysine of S100P in S100P-Induced Cell Migration and Metastasis.
Ismail TM; Gross SR; Lancaster T; Rudland PS; Barraclough R
Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680103
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
